Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in   patients with previously untreated advanced or metastatic adenocarcinoma   of the stomach or gastroesophageal junction: Moonlight, a randomized   phase 2 trial of the German Gastric Group of the AIO.

Document type:: Meeting Abstract
Author(s):: Al-Batran, Salah-Eddin; Pauligk, Claudia; Goetze, Thorsten Oliver; Riera-Knorrenschild, Jorge; Goekkurt, Eray; Angermeier, Stefan; Kullmann, Frank; Thuss-Patience, Peter C.; Homann, Nils; Ettrich, Thomas Jens; Junge, Sabine; Hofheinz, Ralf; Lorenzen, Sylvie
Title:: Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase 2 trial of the German Gastric Group of the AIO.
Journal title abbreviation:: J Clin Oncol
Year:: 2019
Journal volume:: 37 Suppl S
Journal issue:: 15
Fulltext / DOI:: doi:10.1200/JCO.2019.37.15_suppl.TPS4144
Print-ISSN:: 0732-183X
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: